Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
종목 코드 EVO
회사 이름Evotec SE
상장일Oct 11, 1999
설립일2019
CEODr. Christian Wojczewski
직원 수4827
유형Ordinary Share
회계 연도 종료Oct 11
주소Essener Bogen 7
도시HAMBURG
증권 거래소OMX Nordic Exchange Stockholm AB - cash
국가Germany
우편 번호22419
전화4940560810
웹사이트https://www.evotec.com/
종목 코드 EVO
상장일Oct 11, 1999
설립일2019
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음